Letters to the Editor

Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma

National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Trust, London
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Trust, London
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Trust, London
Cancer Clinical Trials Unit, University College London Hospitals NHS Trust, London
Cancer Clinical Trials Unit, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
Department of Haematology, University College London Hospitals NHS Trust, London
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Trust, London, United Kingdom; Department of Haematology, University College London Hospitals NHS Trust, London
Haematologica Early view Aug 25, 2022 https://doi.org/10.3324/haematol.2022.281322